D. Berlau, M. Corrada, E. Head, and C. Kawas, APOE ??2 is associated with intact cognition but increased Alzheimer pathology in the oldest old, Neurology, vol.72, issue.9, pp.829-834, 2009.
DOI : 10.1212/01.wnl.0000343853.00346.a4

S. Bookheimer, M. Strojwas, M. Cohen, A. Saunders, M. Pericak-vance et al., Patterns of Brain Activation in People at Risk for Alzheimer's Disease, New England Journal of Medicine, vol.343, issue.7, pp.450-456, 2000.
DOI : 10.1056/NEJM200008173430701

J. Brown, K. Terashima, A. Burggren, L. Ercoli, K. Miller et al., Brain network local interconnectivity loss in aging APOE-4 allele carriers, Proceedings of the National Academy of Sciences, vol.108, issue.51, pp.20760-20765, 2011.
DOI : 10.1073/pnas.1109038108

D. Bunce, K. Anstey, N. Cherbuin, P. Gautam, P. Sachdev et al., APOE genotype and entorhinal cortex volume in non-demented community-dwelling adults in midlife and early old age, J. Alzheimers Dis, vol.30, issue.4, pp.935-942, 2012.

A. Burggren, M. Zeineh, A. Ekstrom, M. Braskie, P. Thompson et al., Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers, NeuroImage, vol.41, issue.4, pp.1177-1183, 2008.
DOI : 10.1016/j.neuroimage.2008.03.039

K. Chen, N. Ayutyanont, J. Langbaum, A. Fleisher, C. Reschke et al., Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ??4 gene dose in cognitively normal adults: A cross-validation study using voxel-based multi-modal partial least squares, NeuroImage, vol.60, issue.4, pp.2316-2322, 2012.
DOI : 10.1016/j.neuroimage.2012.02.005

K. Chen, E. Reiman, G. Alexander, R. Caselli, R. Gerkin et al., Correlations Between Apolipoprotein E ??4 Gene Dose and Whole Brain Atrophy Rates, American Journal of Psychiatry, vol.164, issue.6, pp.916-921, 2007.
DOI : 10.1176/ajp.2007.164.6.916
URL : http://doi.org/10.1176/ajp.2007.164.6.916

G. Chiang, P. Insel, D. Tosun, N. Schuff, D. Truran-sacrey et al., Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects, Neurology, vol.75, issue.22, pp.1976-1981, 2010.
DOI : 10.1212/WNL.0b013e3181ffe4d1

G. Chiang, P. Insel, D. Tosun, N. Schuff, D. Truran-sacrey et al., Impact of apolipoprotein ??4???cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment, Alzheimer's & Dementia, vol.7, issue.5, pp.514-520, 2011.
DOI : 10.1016/j.jalz.2010.12.010

R. Cohen, C. Small, F. Lalonde, J. Friz, and T. Sunderland, Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women, Neurology, vol.57, issue.12, pp.2223-2228, 2001.
DOI : 10.1212/WNL.57.12.2223

E. Corder, A. Saunders, W. Strittmatter, D. Schmechel, P. Gaskell et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, issue.5123, pp.921-923, 1993.
DOI : 10.1126/science.8346443

N. Dennis, J. Browndyke, J. Stokes, A. Need, J. Burke et al., Temporal lobe functional activity and connectivity in young adult APOE ??4 carriers, Alzheimer's & Dementia, vol.6, issue.4, pp.303-311, 2010.
DOI : 10.1016/j.jalz.2009.07.003

R. Desikan, L. Mcevoy, D. Holland, W. Thompson, J. Brewer et al., Apolipoprotein E epsilon4 does not modulate amyloid-?-associated neurodegeneration

M. Donix, A. Burggren, N. Suthana, P. Siddarth, A. Ekstrom et al., Family History of Alzheimer's Disease and Hippocampal Structure in Healthy People, American Journal of Psychiatry, vol.167, issue.11, pp.1399-1406, 2010.
DOI : 10.1176/appi.ajp.2010.09111575

M. Donix, A. Burggren, N. Suthana, P. Siddarth, A. Ekstrom et al., Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism, NeuroImage, vol.53, issue.1, pp.37-43, 2010.
DOI : 10.1016/j.neuroimage.2010.06.009

M. Donix, G. Small, and S. Bookheimer, Family History and APOE-4 Genetic Risk in Alzheimer???s Disease, Neuropsychology Review, vol.24, issue.4, pp.298-309, 2012.
DOI : 10.1007/s11065-012-9193-2

B. Dubois, H. Feldman, C. Jacova, J. Cummings, S. Dekosky et al., Revising the definition of Alzheimer's disease: a new lexicon, The Lancet Neurology, vol.9, issue.11, pp.1118-1127, 2010.
DOI : 10.1016/S1474-4422(10)70223-4

T. Espeseth, L. Westlye, A. Fjell, K. Walhovd, H. Rootwelt et al., Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ??4, Neurobiology of Aging, vol.29, issue.3, pp.329-340, 2008.
DOI : 10.1016/j.neurobiolaging.2006.10.030

M. Fan, B. Liu, Y. Zhou, X. Zhen, C. Xu et al., Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults, Neuroscience Letters, vol.479, issue.3, pp.332-336, 2010.
DOI : 10.1016/j.neulet.2010.05.092

L. Farrer, L. Cupples, J. Haines, B. Hyman, W. Kukull et al., Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease, JAMA, vol.278, issue.16, pp.1349-1356, 1997.
DOI : 10.1001/jama.1997.03550160069041

C. Fennema-notestine, M. Panizzon, W. Thompson, C. Chen, L. Eyler et al., Presence of ApoE ?4 allele associated with thinner frontal cortex in middle age, J. Alzheimers Dis, vol.26, issue.3, pp.49-60, 2011.

N. Filippini, K. Ebmeier, B. Macintosh, A. Trachtenberg, G. Frisoni et al., Differential effects of the APOE genotype on brain function across the lifespan, NeuroImage, vol.54, issue.1, pp.602-610, 2011.
DOI : 10.1016/j.neuroimage.2010.08.009

N. Filippini, B. Macintosh, M. Hough, G. Goodwin, G. Frisoni et al., Distinct patterns of brain activity in young carriers of the APOE-??4 allele, Proceedings of the National Academy of Sciences, vol.106, issue.17, pp.7209-7214, 2009.
DOI : 10.1073/pnas.0811879106

A. Fleisher, K. Podraza, K. Bangen, C. Taylor, A. Sherzai et al., Cerebral perfusion and oxygenation differences in Alzheimer's disease risk, Neurobiology of Aging, vol.30, issue.11, pp.1737-1748, 2009.
DOI : 10.1016/j.neurobiolaging.2008.01.012

A. Fleisher, K. Chen, X. Liu, N. Ayutyanont, A. Roontiva et al., Apolipoprotein E ??4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease, Neurobiology of Aging, vol.34, issue.1, pp.1-12, 2013.
DOI : 10.1016/j.neurobiolaging.2012.04.017

M. Gallagher and M. Koh, Episodic memory on the path to Alzheimer's disease, Current Opinion in Neurobiology, vol.21, issue.6, pp.929-934, 2011.
DOI : 10.1016/j.conb.2011.10.021

E. Genin, D. Hannequin, D. Wallon, K. Sleegers, M. Hiltunen et al., APOE and Alzheimer disease: a major gene with semi-dominant inheritance, Molecular Psychiatry, vol.67, issue.9, pp.903-907, 2011.
DOI : 10.1056/NEJMoa0809578

S. Han, W. Houston, A. Jak, L. Eyler, B. Nagel et al., Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response, Neurobiology of Aging, vol.28, issue.2, pp.238-247, 2007.
DOI : 10.1016/j.neurobiolaging.2005.12.013

D. Heijer, T. Oudkerk, M. Launer, L. Van-duijn, C. Hofman et al., Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes, Neurology, vol.59, issue.5, pp.746-748, 2002.
DOI : 10.1212/WNL.59.5.746

A. Hinrichs, M. Mintun, D. Head, A. Fagan, D. Holtzman et al., Cortical Binding of Pittsburgh Compound B, an Endophenotype for Genetic Studies of Alzheimer's Disease, Biological Psychiatry, vol.67, issue.6, pp.581-583, 2010.
DOI : 10.1016/j.biopsych.2009.09.012

R. Honea, R. Swerdlow, E. Vidoni, and J. Burns, Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease, Neurology, vol.76, issue.9, pp.822-829, 2011.
DOI : 10.1212/WNL.0b013e31820e7b74

R. Honea, R. Swerdlow, E. Vidoni, J. Goodwin, and J. Burns, Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease, Neurology, vol.74, issue.2, pp.113-120, 2010.
DOI : 10.1212/WNL.0b013e3181c918cb

R. Honea, E. Vidoni, A. Harsha, and J. Burns, Impact of APOE on the Healthy Aging Brain: A Voxel-Based MRI and DTI Study, Journal of Alzheimer's Disease, vol.18, issue.3, pp.553-564, 2009.
DOI : 10.3233/JAD-2009-1163

C. Hostage, R. Choudhury, K. Doraiswamy, P. Petrella, and J. , Dissecting the Gene Dose-Effects of the APOE ??4 and ??2 Alleles on Hippocampal Volumes in Aging and Alzheimer???s Disease, PLoS ONE, vol.21, issue.2, p.54483, 2013.
DOI : 10.1371/journal.pone.0054483.t008

X. Hua, D. Hibar, S. Lee, A. Toga, C. Jack et al., Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans, Neurobiology of Aging, vol.31, issue.8, pp.311463-1480, 2010.
DOI : 10.1016/j.neurobiolaging.2010.04.033

X. Hua, A. Leow, N. Parikshak, S. Lee, M. Chiang et al., Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects, NeuroImage, vol.43, issue.3, pp.458-469, 2008.
DOI : 10.1016/j.neuroimage.2008.07.013

Y. Huang, A??-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease, Trends in Molecular Medicine, vol.16, issue.6, pp.287-294, 2010.
DOI : 10.1016/j.molmed.2010.04.004

Y. Huang and L. Mucke, Alzheimer Mechanisms and Therapeutic Strategies, Cell, vol.148, issue.6, pp.1204-1222, 2012.
DOI : 10.1016/j.cell.2012.02.040

C. Jack, . Jr, R. Petersen, Y. Xu, O. Brien et al., Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease, Annals of Neurology, vol.44, issue.3, pp.303-310, 1998.
DOI : 10.1002/ana.410430307

W. Jagust and S. Landau, Apolipoprotein E, Not Fibrillar ??-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging, Journal of Neuroscience, vol.32, issue.50, pp.18227-18233, 2012.
DOI : 10.1523/JNEUROSCI.3266-12.2012

K. Kantarci, V. Lowe, S. Przybelski, S. Weigand, M. Senjem et al., APOE modifies the association between A?? load and cognition in cognitively normal older adults, Neurology, vol.78, issue.4, pp.232-240, 2012.
DOI : 10.1212/WNL.0b013e31824365ab

J. Kim, J. Basak, and D. Holtzman, The Role of Apolipoprotein E in Alzheimer's Disease, Neuron, vol.63, issue.3, pp.287-303, 2009.
DOI : 10.1016/j.neuron.2009.06.026

J. Kukolja, C. Thiel, T. Eggermann, K. Zerres, and G. Fink, Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE ??4 carriers, Neuroscience, vol.168, issue.2, pp.487-497, 2010.
DOI : 10.1016/j.neuroscience.2010.03.044

H. Lemaître, F. Crivello, C. Dufouil, B. Grassiot, C. Tzourio et al., No ??4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects, NeuroImage, vol.24, issue.4, pp.1205-1213, 2005.
DOI : 10.1016/j.neuroimage.2004.10.016

J. Lind, A. Larsson, J. Persson, M. Ingvar, L. Nilsson et al., Reduced hippocampal volume in non-demented carriers of the apolipoprotein E ??4: Relation to chronological age and recognition memory, Neuroscience Letters, vol.396, issue.1, pp.23-27, 2006.
DOI : 10.1016/j.neulet.2005.11.070

Y. Liu, T. Paajanen, E. Westman, L. Wahlund, A. Simmons et al., Effect of APOE ??4 Allele on Cortical Thicknesses and Volumes: The AddNeuroMed Study, Journal of Alzheimer's Disease, vol.21, issue.3, pp.947-966, 2010.
DOI : 10.3233/JAD-2010-100201

Y. Liu, T. Paajanen, E. Westman, Y. Zhang, L. Wahlund et al., APOE ?2 allele is associated with larger regional cortical thicknesses and volumes, Dement. Geriatr. Cogn. Disord, vol.30, issue.3, pp.229-237, 2010.

C. Liu, T. Kanekiyo, H. Xu, and G. Bu, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nature Reviews Neurology, vol.67, issue.2, pp.106-124, 2013.
DOI : 10.1038/nrneurol.2012.263

P. Lu, P. Thompson, A. Leow, G. Lee, A. Lee et al., Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study, J. Alzheimers Dis, vol.23, issue.3, pp.433-442, 2011.

C. Mathis, L. Kuller, W. Klunk, B. Snitz, J. Price et al., In vivo assessment of amyloid-?? deposition in nondemented very elderly subjects, Annals of Neurology, vol.77, issue.pt 12, 2012.
DOI : 10.1002/ana.23797

M. Mielke, H. Wiste, S. Weigand, D. Knopman, V. Lowe et al., Indicators of amyloid burden in a population-based study of cognitively normal elderly, Neurology, vol.79, issue.15, pp.1570-1577, 2012.
DOI : 10.1212/WNL.0b013e31826e2696

J. Morra, Z. Tu, L. Apostolova, A. Green, C. Avedissian et al., Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls, NeuroImage, vol.45, issue.1, pp.3-15, 2009.
DOI : 10.1016/j.neuroimage.2008.10.043

J. Morris, C. Roe, C. Xiong, A. Fagan, A. Goate et al., predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging, Annals of Neurology, vol.164, issue.1, pp.122-131, 2010.
DOI : 10.1002/ana.21843

L. Mosconi, M. Brys, R. Switalski, R. Mistur, L. Glodzik et al., Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism, Proceedings of the National Academy of Sciences, vol.104, issue.48, pp.19067-19072, 2007.
DOI : 10.1073/pnas.0705036104

L. Mosconi, R. Mistur, R. Switalski, M. Brys, L. Glodzik et al., Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease, Neurology, vol.72, issue.6, pp.513-520, 2009.
DOI : 10.1212/01.wnl.0000333247.51383.43

S. Mueller, N. Schuff, S. Raptentsetsang, J. Elman, and M. Weiner, Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4??T, NeuroImage, vol.42, issue.1, pp.42-48, 2008.
DOI : 10.1016/j.neuroimage.2008.04.174

S. Mueller and M. Weiner, Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields, Hippocampus, vol.265, issue.6, pp.558-564, 2009.
DOI : 10.1002/hipo.20614

K. Murphy, S. Landau, K. Choudhury, C. Hostage, K. Shpanskaya et al., Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth, NeuroImage, vol.78, pp.474-480, 2013.
DOI : 10.1016/j.neuroimage.2013.04.048

O. Dwyer, L. Lamberton, F. Matura, S. Tanner, C. Scheibe et al., Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study, PLoS ONE, vol.70, issue.11, p.48895, 2012.
DOI : 10.1371/journal.pone.0048895.t006

B. Plassman, K. Welsh-bohmer, E. Bigler, S. Johnson, C. Anderson et al., Apolipoprotein E ??4 allele and hippocampal volume in twins with normal cognition, Neurology, vol.48, issue.4, pp.985-989, 1997.
DOI : 10.1212/WNL.48.4.985

H. Protas, K. Chen, J. Langbaum, A. Fleisher, G. Alexander et al., Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease, JAMA Neurology, vol.70, issue.3, pp.320-325, 2013.
DOI : 10.1001/2013.jamaneurol.286

E. Reiman, R. Caselli, L. Yun, K. Chen, D. Bandy et al., Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E, N. Engl. J

E. Reiman, K. Chen, G. Alexander, R. Caselli, D. Bandy et al., Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia, Proc. Natl. Acad
DOI : 10.1073/pnas.2635903100

E. Reiman, K. Chen, G. Alexander, R. Caselli, D. Bandy et al., From The Cover: Correlations between apolipoprotein E ??4 gene dose and brain-imaging measurements of regional hypometabolism, Proceedings of the National Academy of Sciences, vol.102, issue.23, pp.8299-8302, 2005.
DOI : 10.1073/pnas.0500579102

E. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu et al., Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease, Proc. Natl. Acad. Sci. U

E. Reiman, A. Uecker, R. Caselli, S. Lewis, D. Bandy et al., Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease, Annals of Neurology, vol.48, issue.2, pp.288-291, 1998.
DOI : 10.1002/ana.410440226

S. Risacher, L. Shen, J. West, S. Kim, B. Mcdonald et al., Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort, Neurobiology of Aging, vol.31, issue.8, pp.311401-1418, 2010.
DOI : 10.1016/j.neurobiolaging.2010.04.029

K. Rodrigue, K. Kennedy, M. Devous, . Sr, J. Rieck et al., ??-Amyloid burden in healthy aging: Regional distribution and cognitive consequences, Neurology, vol.78, issue.6, pp.387-395, 2012.
DOI : 10.1212/WNL.0b013e318245d295

C. Rowe, K. Ellis, M. Rimajova, P. Bourgeat, K. Pike et al., Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging, Neurobiology of Aging, vol.31, issue.8, pp.311275-1283, 2010.
DOI : 10.1016/j.neurobiolaging.2010.04.007
URL : https://hal.archives-ouvertes.fr/hal-00910171

A. Saunders, K. Schmader, J. Breitner, M. Benson, W. Brown et al., Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases, The Lancet, vol.342, issue.8873, pp.710-711, 1993.
DOI : 10.1016/0140-6736(93)91709-U

H. Schipper, Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment, Neurobiology of Aging, vol.32, issue.5, pp.778-790, 2011.
DOI : 10.1016/j.neurobiolaging.2009.04.021

H. Schmidt, R. Schmidt, F. Fazekas, J. Semmler, P. Kapeller et al., Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates, Clinical Genetics, vol.340, issue.5, pp.293-299, 1996.
DOI : 10.1111/j.1399-0004.1996.tb02377.x

N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L. Shaw et al., MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers, Brain, vol.132, issue.4
DOI : 10.1093/brain/awp007

P. Shaw, J. Lerch, J. Pruessner, K. Taylor, A. Rose et al., Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study, The Lancet Neurology, vol.6, issue.6, pp.494-500, 2007.
DOI : 10.1016/S1474-4422(07)70106-0

Y. Sheline, J. Morris, A. Snyder, J. Price, Z. Yan et al., APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF A??42, Journal of Neuroscience, vol.30, issue.50, pp.17035-17040, 2010.
DOI : 10.1523/JNEUROSCI.3987-10.2010

G. Small, J. Mazziotta, M. Collins, L. Baxter, M. Phelps et al., Apolipoprotein E Type 4 Allele and Cerebral Glucose Metabolism in Relatives at Risk for Familial Alzheimer Disease, JAMA: The Journal of the American Medical Association, vol.273, issue.12, pp.942-947, 1995.
DOI : 10.1001/jama.1995.03520360056039

G. Small, L. Ercoli, D. Silverman, S. Huang, S. Komo et al., Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease, Proc. Natl. Acad
DOI : 10.1073/pnas.090106797

G. Small, P. Siddarth, A. Burggren, V. Kepe, L. Ercoli et al., Influence of Cognitive Status, Age, and APOE-4 Genetic Risk on Brain FDDNP Positron-Emission Tomography Imaging in Persons Without Dementia, Archives of General Psychiatry, vol.66, issue.1, pp.81-87, 2009.
DOI : 10.1001/archgenpsychiatry.2008.516

H. Soininen, K. Partanen, A. Pitkänen, M. Hallikainen, T. Hänninen et al., Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ??4 allele, Neurology, vol.45, issue.2, pp.391-392, 1995.
DOI : 10.1212/WNL.45.2.391

R. Sperling, P. Aisen, L. Beckett, D. Bennett, S. Craft et al., Toward defining the preclinical stages of Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.280-292, 2011.
DOI : 10.1016/j.jalz.2011.03.003

N. Suthana, A. Krupa, M. Donix, A. Burggren, A. Ekstrom et al., Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease, NeuroImage, vol.53, issue.3
DOI : 10.1016/j.neuroimage.2009.12.014

M. Thambisetty, L. Beason-held, Y. An, M. Kraut, and S. Resnick, APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging, Arch. Neurol, vol.67, issue.1, pp.93-98, 2010.

H. Tohgi, S. Takahashi, E. Kato, A. Homma, R. Niina et al., Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ??4 allele, Neuroscience Letters, vol.236, issue.1, pp.21-24, 1997.
DOI : 10.1016/S0304-3940(97)00743-X

A. Trachtenberg, N. Filippini, J. Cheeseman, E. Duff, M. Neville et al., The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease, Neurobiology of Aging, vol.33, issue.3, pp.618-619, 2012.
DOI : 10.1016/j.neurobiolaging.2010.11.011

E. Tuminello and S. Han, The Apolipoprotein E Antagonistic Pleiotropy Hypothesis: Review and Recommendations, International Journal of Alzheimer's Disease, vol.164, issue.1, p.726197, 2011.
DOI : 10.1523/JNEUROSCI.3785-09.2010

P. Vemuri, H. Wiste, S. Weigand, D. Knopman, L. Shaw et al., Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease, Ann. Neurol, vol.67, issue.3, pp.308-316, 2010.

V. Villemagne, K. Pike, G. Chetelat, K. Ellis, R. Mulligan et al., Longitudinal assessment of A?? and cognition in aging and Alzheimer disease, Annals of Neurology, vol.29, issue.1, pp.181-192, 2011.
DOI : 10.1002/ana.22248

A. Vlassenko, M. Mintun, C. Xiong, Y. Sheline, A. Goate et al., Amyloid-beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data, Annals of Neurology, vol.66, issue.5, pp.857-861, 2011.
DOI : 10.1002/ana.22608

E. Westlye, A. Lundervold, H. Rootwelt, A. Lundervold, and L. Westlye, Increased hippocampal default mode synchronization during rest in middle-aged and elderly APOE ?4 carriers: relationships with memory performance, J. Neurosci, issue.21, pp.317775-7783, 2011.

H. Wishart, A. Saykin, T. Mcallister, L. Rabin, B. Mcdonald et al., Regional brain atrophy in cognitively intact adults with a single APOE ??4 allele, Neurology, vol.67, issue.7, pp.1221-1224, 2006.
DOI : 10.1212/01.wnl.0000238079.00472.3a